Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CK1-IN-3

Copy Product Info
😃Good
Catalog No. T60005Cas No. 349438-74-0

CK1-IN-3 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, inflammation diseases.

CK1-IN-3

CK1-IN-3

Copy Product Info
😃Good
Purity: 99.18%
Catalog No. T60005Cas No. 349438-74-0
CK1-IN-3 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, inflammation diseases.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$30In StockIn Stock
5 mg$68In StockIn Stock
10 mg$103In StockIn Stock
25 mg$188In StockIn Stock
50 mg$271In StockIn Stock
100 mg$372-In Stock
200 mg$510-In Stock
1 mL x 10 mM (in DMSO)$75In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.18%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

CK1-IN-3 AI Summary
CK1-IN-3 exhibits bioactivities including the inhibition of human recombinant CK-1delta with an IC50 of 2220.0 nM using casein as a substrate after 60 minutes, as measured by the Kinase-Glo assay. It also demonstrates over 60.0% inhibition of human recombinant CK-1delta at a concentration of 10 μM under the same conditions. Additionally, CK1-IN-3 shows neuroprotective activity in Drosophila melanogaster expressing human TDP-43, resulting in a mean lifespan of 36.17 days at a concentration of 100 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
CK1-IN-3 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, inflammation diseases.
Targets&IC50
CK1δ:2.22 μM
Chemical Properties
Molecular Weight328.39
FormulaC17H16N2O3S
Cas No.349438-74-0
SmilesN(C(CC1=C(OC)C=CC=C1)=O)C2=NC=3C(S2)=CC(OC)=CC3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (152.26 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.0452 mL15.2258 mL30.4516 mL152.2580 mL
5 mM0.6090 mL3.0452 mL6.0903 mL30.4516 mL
10 mM0.3045 mL1.5226 mL3.0452 mL15.2258 mL
20 mM0.1523 mL0.7613 mL1.5226 mL7.6129 mL
50 mM0.0609 mL0.3045 mL0.6090 mL3.0452 mL
100 mM0.0305 mL0.1523 mL0.3045 mL1.5226 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CK1-IN-3 | purchase CK1-IN-3 | CK1-IN-3 cost | order CK1-IN-3 | CK1-IN-3 chemical structure | CK1-IN-3 formula | CK1-IN-3 molecular weight